Literature DB >> 8617479

p53 protein overexpression in gallbladder carcinoma and its precursor lesions: an immunohistochemical study.

I I Wistuba1, A F Gazdar, I Roa, J Albores-Saavedra.   

Abstract

Gallbladder carcinoma is one of the most frequent neoplasms diagnosed in Chile. Although the premalignant lesions have been extensively studied and are well characterized, there is only limited information about the genetic abnormalities that might be important in the pathogenesis of gallbladder carcinoma or that might have prognostic implications. The present study evaluates the immunohistochemical expression of p53 protein in premalignant lesions and invasive carcinoma of the gallbladder, and correlates the p53 expression with histological type, grade of differentiation, and level of invasion of the tumor. The authors studied the immunohistochemical p53 protein overexpression in 52 gallbladder carcinomas, 47 carcinomas in situ (CISs), 34 dysplasias, and 10 specimens with chronic cholecystitis containing normal and metaplastic epithelium. A semiquantitative scoring system was used to assess the p53 reactivity. p53 overexpression was found in 34 of 52 (65.4%) carcinomas, 21 of 47 (44.7%) CISs, and 11 of 34 (32.4%) dysplasias. There were no significant differences in p53 expression in premalignant lesions associated with invasive carcinoma and those that were not. Normal and metaplastic epithelium did not overexpress p53 protein. In adenocarcinomas, no correlation was found between p53 protein overexpression and histological subtype, grade of differentiation, or level of invasion. The high incidence of p53 overexpression in gallbladder carcinoma and its presence in dysplasia, even in specimens without invasive carcinomas, suggests that this abnormality is an important and early event in the pathogenesis of the tumor. The progressively increasing incidence of p53 overexpression observed from premalignant lesions to invasive tumor provides additional support to the view that this is the usual route for the development of infiltrating gallbladder carcinoma.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8617479     DOI: 10.1016/s0046-8177(96)90109-4

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Prediction of prognosis in gallbladder carcinoma by mucin and p53 immunohistochemistry.

Authors:  Mayuko Takagawa; Naoki Muguruma; Kaori Oguri; Yoshitaka Imoto; Koichi Okamoto; Kunio Ii; Susumu Ito
Journal:  Dig Dis Sci       Date:  2005-08       Impact factor: 3.199

Review 2.  Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy.

Authors:  Takahiko Funabiki; Toshiki Matsubara; Shuichi Miyakawa; Shin Ishihara
Journal:  Langenbecks Arch Surg       Date:  2008-05-24       Impact factor: 3.445

3.  Hyperplastic polyp of the gallbladder associated with pancreaticobiliary maljunction in a 9-year-old girl.

Authors:  Tadao Okada; Fumiaki Sasaki; Shohei Honda; Yoshihiro Matsuno; Kanako Kubota; Satoru Todo
Journal:  Pediatr Surg Int       Date:  2009-11       Impact factor: 1.827

4.  Pancreaticobiliary maljunction: pathophysiological and clinical aspects and the impact on biliary carcinogenesis.

Authors:  Yoshiro Matsumoto; Hideki Fujii; Jun Itakura; Masanori Matsuda; Yang Yang; Bunsei Nobukawa; Kohichi Suda
Journal:  Langenbecks Arch Surg       Date:  2003-04-09       Impact factor: 3.445

5.  Severe dysplasia of the gallbladder associated with occult pancreatobiliary reflux.

Authors:  Jin Kan Sai; Masafumi Suyama; Bunsei Nobukawa; Yoshihiro Kubokawa; Nobuhiro Sato
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

Review 6.  Risk factors for gallbladder cancer and cholangiocarcinoma: similarities, differences and updates.

Authors:  Tarun Rustagi; Constantin A Dasanu
Journal:  J Gastrointest Cancer       Date:  2012-06

7.  Is there a role for estrogen and progesterone receptors in gall bladder cancer?

Authors:  P J Shukla; S G Barreto; P Gupta; R Neve; M Ramadwar; K Deodhar; S Mehta; S V Shrikhande; K M Mohandas
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

8.  Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.

Authors:  Jean M Butte; Javiera Torres; Emanuela F Veras; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Manuel Meneses; Yoshiyaki Inayama; Yuman Fong; Ronald P Dematteo; Hernan De La Fuente; Itaru Endo; David S Klimstra; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2012-12-01       Impact factor: 5.344

9.  Gallbladder carcinoma: the role of p53 protein overexpression and Ki-67 antigen expression as prognostic markers.

Authors:  Luis A Hidalgo Grau; Josep M Badia; Carmen Admella Salvador; Teresa Soler Monsó; Josep Feliu Canaleta; Josep M Gubern Nogués; Javier Suñol Sala
Journal:  HPB (Oxford)       Date:  2004       Impact factor: 3.647

10.  Two distinct pathways of p16 gene inactivation in gallbladder cancer.

Authors:  Hiroyuki Tadokoro; Takako Shigihara; Tomomi Ikeda; Masaru Takase; Masafumi Suyama
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.